Clinical Trial Update: Phase 2 Study of the RSV/Flu-01E Vaccine Against Respiratory Syncytial Virus Infection in Older Adults [Phase 2]

View source ↗

Summary

Phase 2 study of the RSV/Flu-01E vaccine in older adults has completed, sponsored by the Research Institute of Influenza in Russia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• RSV/Flu-01E vaccine (RSV/Flu-01E vaccine)

Snippet

Sponsor: Research Institute of Influenza, Russia | Conditions: Respiratory Synctial Virus Infections | Phase 2 | Status: COMPLETED